Follow the 샤페론 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 샤페론 has logged 32 insider filings. Market capitalisation: €19.3bn. The latest transaction was filed on 29 June 2026 (Purchase). Among the most active insiders: 유안타인베스트먼트. Every trade is openly available.
32
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
19 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,878 of 27,906 companies
2.1
score / 100
Value
2
Quality
2
FCF yld-77%
Earn yld-80%
EV/EBITDA·
ROE-92%
Gross mgn-41%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
샤페론 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.